Peer Review History

Original SubmissionJune 20, 2020
Decision Letter - Frank T. Spradley, Editor

PONE-D-20-18978

Prevalence and associated factors of anemia among reproductive-aged women in Eastern Africa; a multilevel analysis of the recent DHS data.

PLOS ONE

Dear Dr. Teshale,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

SPECIFIC ACADEMIC EDITOR COMMENTS: An expert in the field handled your manuscript. We really appreciate their time and efforts. Although interest was found in your study, some major concerns and comments reduced this enthusiasm. There are comments about revising several statements to increase clarity; additional details about the methods need to be provided; there are questions about the data analyses; and the discussion should be rewritten to better focus on the main and novel findings. Please address ALL of the reviewer's comments in your revised manuscript.

Please submit your revised manuscript by Aug 28 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Frank T. Spradley

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript by Teshale and colleagues explored the prevalence and associated factors of anemia among reproductive-aged women in Eastern Africa. The authors used a weighted and large sample of DHS data. The authors found a high prevalence of anemia in east Africa with spatial variations. The authors delineated possible associated factors using appropriate statistical techniques. The following suggestions can strengthen the manuscript:

Abstract

1. Change “Anemia in reproductive age women” to “Anemia in women of reproductive age."

2. For culture appropriateness, “restrain to “low- and middle-income countries" as opposed to "developing countries."

3. Start a new sentence with “This study aimed to”

4. Change” …using the nine eastern African countries DHS data” to using DHS data of 9 eastern African countries,”

5. Defined DHS at the first mention or avoid abbreviation in the abstract.

6. Delete “and variables with p-value <0.05 in the multivariable analysis were declared as significant determinants of anemia."

Background

1. Line 50: delete "developing."

2. Line 50-57: For coherence, separate the effect of anemia women and their offspring separately.

3. Line 63-64: Add in 2011. As you know, the prevalence should be stated with a time period.

4. Remove "developing countries" to replace them with LMIC.

5. Please clearly state the objective of threw study in the last paragraph of the background before starting line 80.

6. In addition, please state your hypothesis

Method

1. Change "method" to "methods."

2. Cite line 90

3. Please write all “reproductive-age women" to "women of reproductive age."

4. Give the rationales for choosing the confounding factors to adjust for.

5. Line 115: The DHS uses a different categorization of wealth index, please use them as opposed to poorest/poorer

6. Line 124: Since the prevalence of the outcome of interest is very high (35%), the odds ratio can overestimate the prevalence ratio using logistic regression. Although the use of odds ratios is correct, authors should consider prevalence ratios analysis by employing either log-binomial or Poisson regression “see Barros, A. J., & Hirakata, V. N. (2003). Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC medical research methodology, 3(1), 21. See use of log-binomial analysis in anemia prevalence" https://link.springer.com/article/10.1186/s12884-020-03064-x]

7.

8.

9. Describe the methods of sample weighting. Was additional weighting with the population of the country done?

10. Line 134: Authors should explain why started methods of model comparison such as AIC/BIC were not used

Results:

1. I recommend adding a geographical map depicting the distribution of anemia in East Africa.

Discussion

1. As stated on line 247-248, infectious diseases such as malaria and HIV substantially contribute to anemia in the population in LMICs. However, the authors never explored their effect in this study, and yet malaria and HIV data are available in the DHS records. For the recent similar study for the west and central Africa, see Ssentongo, P., Ba, D. M., Ssentongo, A. E., Ericson, J. E., Wang, M., Liao, D., & Chinchilli, V. M. (2020). Associations of malaria, HIV, and coinfection, with anemia in pregnancy in sub-Saharan Africa: a population-based cross-sectional study. BMC Pregnancy and Childbirth, 20(1), 1-11.

2. The should consider cut down the discussion to focus on the main findings and continue to provide 2-3 paragraphs explaining their results in light of other studies. The final section should be the clinical and public health implications and finally, the limitations. The authors do not have to discuss every result.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Paddy Ssentongo, MD, MPH

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Date: August 10, 2020

Author’s response to editor and reviewer

Title: Prevalence and associated factors of anemia among reproductive-aged women in Eastern Africa; a multilevel analysis of the recent DHS data.

Manuscript number: PONE-D-20-18978

Dear editor/reviewer: We have now thoroughly updated the manuscript. We hope the improvements are sufficient and if that is not the case, any suggestions/comments are welcome. Below we present a point-by - point response to the questions raised by the editor & reviewer, to whom we thank for their valuable contributions to this research.

Editor’s comment

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

Author’s response: Dear editor thank you. We amended our manuscript according to the journal style.

Reviewer #1: Dr. Paddy Ssentongo

1. Change “Anemia in reproductive age women” to “Anemia in women of reproductive age."

Author’s response: thank you for the comment we amended to read as “anemia in reproductive age women” throughout the revised document (see the track change)

2. For culture appropriateness, “restrain to “low- and middle-income countries" as opposed to "developing countries."

Author’s response: Corrected in the revised paper.

3. Start a new sentence with “This study aimed to”

Author’s response: Amended in the revised paper

4. Change” …using the nine eastern African countries DHS data” to using DHS data of 9 eastern African countries,”

Author’s response: Corrected in the revised manuscript

5. Defined DHS at the first mention or avoid abbreviation in the abstract.

Author’s response: We first mentioned it as “Demographic and Health Survey (DHS)” in the revised manuscript

6. Delete “and variables with p-value <0.05 in the multivariable analysis were declared as significant determinants of anemia."

Author’s response: Thank you. We deleted in the revised manuscript.

7. Line 50: delete "developing."

Author’s response: Deleted

8. Line 50-57: For coherence, separate the effect of anemia women and their offspring separately (paragraph 2 line 53-58).

Author’s response: Thank you for the important concern you raised. We consider it and put the effects of anemia for women and the newborn/offspring separately.

9. Line 63-64: Add in 2011. As you know, the prevalence should be stated with a time period.

Author’s response: The time (2011) is added in the revised manuscript.

10. Remove "developing countries" to replace them with LMIC.

Author’s response: Thank you we removed it

11. Please clearly state the objective of threw study in the last paragraph of the background before starting line 80.

Author’s response: thank you. We consider it in the revised manuscript (see the last paragraph of the background section).

12. In addition, please state your hypothesis

Author’s response: We stated the hypothesis in the revised manuscript (found in the last paragraph of the revised manuscript).

13. Change "method" to "methods."

Author’s response: Changed

14. Cite line 90

Author’s response: Thank you. We add citation/reference

15. Please write all “reproductive-age women" to "women of reproductive age."

Author’s response: We amended it throughout the revised manuscript

16. Give the rationales for choosing the confounding factors to adjust for.

Author’s response: Thank you for raising the important concern. We choose the confounding factors based on reviewing of literatures, based on clinical judgment/importance, as well as based on their availability in the DHSs.

17. Line 115: The DHS uses a different categorization of wealth index, please use them as opposed to poorest/poorer

Author’s response: Thank you for your comment. We amended the terms to read as household wealth quantiles [first, second, middle, fourth, and highest] in the revised manuscript.

18. Line 124: Since the prevalence of the outcome of interest is very high (35%), the odds ratio can overestimate the prevalence ratio using logistic regression. Although the use of odds ratios is correct, authors should consider prevalence ratios analysis by employing either log-binomial or Poisson regression “see Barros, A. J., & Hirakata, V. N. (2003). Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC medical research methodology, 3(1), 21. See use of log-binomial analysis in anemia prevalence" https://link.springer.com/article/10.1186/s12884-020-03064-x]

Author’s response: We really thank you for this important concern and direction. We were trying to fit a multilevel log-binomial model in order to calculate the prevalence ratio (rather than the odds ratio) for a clustered binary outcome using stata [using the command meglm depvar indvar || v001: , family(binomial) link(log) eform ], unfortunately we have got an unexpected error which says link log is not allowed with family Bernoulli. Therefore, we consider a reasonable analytic option that is we use Poisson regression with robust standard errors to overcome the over estimation of the prevalence ratio (an important measure of association if the outcome of interest is common) as stated by [Coutinho L, Scazufca M, Menezes PR, 2008, Zou G, 2004, and Barros, A.J., Hirakata, V.N, 2003].

19. Describe the methods of sample weighting. Was additional weighting with the population of the country done?

Author’s response: Just we appended the data and we weight it using the weighting factor.

20. Line 134: Authors should explain why started methods of model comparison such as AIC/BIC were not used

Author’s response: Since the models were nested we used deviance (the preferable method for model comparison for nested models)

21. I recommend adding a geographical map depicting the distribution of anemia in East Africa.

Author’s response: Thank you for your comment. We added the map displaying the prevalence of anemia in the revised manuscript (see figure 2).

22. As stated on line 247-248, infectious diseases such as malaria and HIV substantially contribute to anemia in the population in LMICs. However, the authors never explored their effect in this study, and yet malaria and HIV data are available in the DHS records. For the recent similar study for the west and central Africa, see Ssentongo, P., Ba, D. M., Ssentongo, A. E., Ericson, J. E., Wang, M., Liao, D., & Chinchilli, V. M. (2020). Associations of malaria, HIV, and coinfection, with anemia in pregnancy in sub-Saharan Africa: a population-based cross-sectional study. BMC Pregnancy and Childbirth, 20(1), 1-11.

Author’s response: Thank you for your important question. Even though infectious diseases (such as malaria, HIV/AIDS, and intestinal parasites) are known to contribute to anemia, we used the IR (individual women) data set, for this study, in which there was no such variables in most of the surveys. Moreover, they are found as separate file/data and difficult to access and append these data. For example, in Ethiopia information about malaria is not found in the EDHS 2016 (IR data set), rather it is found as separate data (as malaria indicator survey). Therefore, we acknowledge it as limitation of our study (see the limitation section)

23. The should consider cut down the discussion to focus on the main findings and continue to provide 2-3 paragraphs explaining their results in light of other studies. The final section should be the clinical and public health implications and finally, the limitations. The authors do not have to discuss every result.

Author’s response: Dear reviewer thank you for your important concern. Even though. it is difficult to cut down the discussion section in to 2/3 paragraphs (since we had many findings) we tried to concentrate and discuss the most important variables. We also putted the strength/implications, as well as the limitations of our study in the last paragraph of the discussion section.

Dear reviewer

We made a re-analysis based on your concern / comment, as well as due to the inclusion of Zambia DHS (2018), which was previously missed in view of the previous Zambian DHS (ZDHS 2013). So, our study was based on 10 East African DHSs with a weighted sample of 101524 women of reproductive age.

References

Coutinho L, Scazufca M, Menezes PR. Methods for estimating prevalence ratios in cross-sectional studies. Revista de saude publica. 2008 Dec;42(6):992-8.

Zou G. A modified poisson regression approach to prospective studies with binary data. American journal of epidemiology. 2004 Apr 1;159(7):702-6.

Barros, A.J., Hirakata, V.N. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 3, 21 (2003). https://doi.org/10.1186/1471-2288-3-21

Blumenberg, Cauane. (2017). Re: How can we calculate prevalence ratio from Poisson regression?. Retrieved from: https://www.researchgate.net/post/How_can_we_calculate_prevalence_ratio_from_Poisson_regression/58744263615e27dd6f318ca7/citation/download.

Attachments
Attachment
Submitted filename: Response to reviewer.docx
Decision Letter - Frank T. Spradley, Editor

Anemia and its associated factors among women of reproductive age in Eastern Africa: a Multilevel Mixed-effects Generalized Linear Model

PONE-D-20-18978R1

Dear Dr. Teshale,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Frank T. Spradley

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have addressed all my comments. The manuscript is clearly written and the statistics are robust.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Paddy Ssentongo, MD, MPH

Formally Accepted
Acceptance Letter - Frank T. Spradley, Editor

PONE-D-20-18978R1

Anemia and its associated factors among women of reproductive age in Eastern Africa: a Multilevel Mixed-effects Generalized Linear Model

Dear Dr. Teshale:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Frank T. Spradley

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .